Skip Navigation


Carcinogenesis Advance Access originally published online on April 1, 2008
Carcinogenesis 2008 29(8):1493-1499; doi:10.1093/carcin/bgn088
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/8/1493    most recent
bgn088v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Salnikow, K.
Right arrow Articles by Niederhuber, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salnikow, K.
Right arrow Articles by Niederhuber, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2008.

Regulation of hypoxia-inducible genes by ETS1 transcription factor

Konstantin Salnikow1,*, Olga Aprelikova2, Sergey Ivanov3, Sean Tackett2, Monika Kaczmarek1, Aldona Karaczyn1, Herman Yee4, Kazimierz S. Kasprzak1 and John Niederhuber2

1 Laboratory of Comparative Carcinogenesis, National Cancer Institute at Frederick, Frederick, MD 21702, USA
2 Laboratory of Tumor and Stem Cell Biology, National Cancer Institute, Bethesda, MD 20892, USA
3 Department of Cardiothoracic Surgery
4 Department of Pathology, New York University School of Medicine, New York, NY 10016, USA

* To whom correspondence should be addressed. Tel: +1 301 846 5623; Fax: +1 301 846 5946; Email: salnikow{at}ncifcrf.gov

Hypoxia-inducible factor (HIF-1) regulates the expression of genes that facilitate tumor cell survival by making them more resistant to therapeutic intervention. Recent evidence suggests that the activation of other transcription factors, in cooperation with HIF-1 or acting alone, is involved in the upregulation of hypoxia-inducible genes. Here we report that high cell density, a condition that might mimic the physiologic situation in growing tumor and most probably representing nutritional starvation, upregulates hypoxia-inducible genes. This upregulation can occur in HIF-independent manner since hypoxia-inducible genes carbonic anhydrase 9 (CA9), lysyloxidase like 2 (LOXL2) and n-myc-down regulated 1 (NDRG1)/calcium activated protein (Cap43) can be upregulated by increased cell density under both normoxic and hypoxic conditions in both HIF-1{alpha}-proficient and -deficient mouse fibroblasts. Moreover, cell density upregulates the same genes in 1HAEo– and A549 human lung epithelial cells. Searching for other transcription factors involved in the regulation of hypoxia-inducible genes by cell density, we focused our attention on ETS1. As reported previously, members of v-ets erythroblastosis virus E26 oncogene homolog (ETS) family transcription factors participate in the upregulation of hypoxia-inducible genes. Here, we provide evidence that ETS1 protein is upregulated at high cell density in both human and mouse cells. The involvement of ETS1 in the upregulation of hypoxia-inducible genes was further confirmed in a luciferase reporter assay using cotransfection of ETS1 expression vector with NDRG1/Cap43 promoter construct. The downregulation of ETS1 expression with small interfering RNA (siRNA) inhibited the upregulation of CA9 and NDRG1/Cap43 caused by increased cell density. Collectively, our data indicate the involvement of ETS1 along with HIF-1 in regulating hypoxia-inducible genes.

Abbreviations: CA9, carbonic anhydrase 9; Cap43, calcium activated protein; ETS, v-ets erythroblastosis virus E26 oncogene homolog; HD, high density; HIF-1, hypoxia-inducible factor; LD, low density; LOX, lysyloxidase; LOXL2, lysyloxidase like 2; NDRG1, n-myc-down regulated 1; PCR, polymerase chain reaction; siRNA, small interfering RNA

Received November 15, 2007; revised February 25, 2008; accepted March 15, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
K. A. Sloan, H. A. Marquez, J. Li, Y. Cao, A. Hinds, C. J. O'Hara, S. Kathuria, M. I. Ramirez, M. C. Williams, and H. Kathuria
Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines
Carcinogenesis, August 1, 2009; 30(8): 1433 - 1442.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.